00:00
Welcome back. We’re going to talk about a significant and important cause of heart
disease, which happens quite commonly in the human population due to hypertension.
00:13
And it’s not just high blood pressure necessarily in the systemic circulation, in the arterial
circulation, you can also have pulmonary hypertension related to increased pressure
in the pulmonary circulation causing right heart failure. So, we’re going to talk about
both. Here’s our model of a normal heart. We can see, again, just for orientation,
on the left-hand side we have the superior vena cava, inferior vena cava coming into
the right atrium crossing the tricuspid valve into the right ventricle and out through
the lungs. All of that is indicated in blue. Blood will return through the pulmonary veins,
through the mitral valve into the left ventricle and out the aorta. All of that is indicated
in pink. Note, the relative thickness of the ventricular walls. Alright, if we have normal
pressure such as indicated here, then the heart muscle has a certain thickness to the
walls, left ventricle slightly, in fact moderately more thickened than the left ventricle
because it has to sustain higher systemic pressures. Average would be 120 systolic
over 80 mmHg diastolic. Now, if we have pressure overload, so increased systemic
pressures as we talked about in the previous talk, having to do with what causes
hypertension. If we have increased systemic pressures, the left ventricle responds
by undergoing hypertrophy. I can’t get more heart muscle cells, that’s just not the
way it works, these are terminally differentiated cells. So, I have to make each individual
cell have more sarcomeres so it can squeeze more effectively. The cells are going to
get big. So, there’s going to be cellular hypertrophy. As a result, the left ventricle wall
becomes hypertrophic, thickened. Okay, so what does this mean though, down at the
cellular and kind of even the molecular level. Well, the individual cells have to get bigger.
02:16
They undergo myocyte hypertrophy. That’s adaptive. Myocyte hypertrophy is adaptive,
but only up to a point because there’s an increased diffusion distance now between
the capillaries around each cardiac myocyte, and as the cells get bigger and bigger and
bigger, that capillary density doesn’t increase. So, there now is going to be a relative
diffusion radiant of oxygen and nutrition into the middle of these large hypertrophied
myocytes. That means that there is potential for low-grade ischemia and a potential for
arrhythmias because we have abnormal ATP generation and, therefore, abnormal
movement of various ions. So, it’s not completely perfectly, wonderful adaptive.
03:05
It can, after a period of time, become maladaptive. There’s also, as we stress the heart
and make it work harder, we’re going to have increased intracellular organelle or turnover
and we’re going to have increased matrix production. So, not only are the cardiac
myocytes feeling this increased pressure and the need to squeeze harder, the fibroblast
that composed maybe 25% or 30% of the cellularity of the heart are also going to feel
this increased pressure. Their response is to make more matrix. Ooopps, that makes the
heart stiffer. So, now we’re going to have diastolic dysfunction; the heart won’t
relax very well. It may squeeze, okay up to a point, but with that increased fibrosis due to
increased matrix production by all those fibroblasts, we’re going to have a stiffer heart.
03:56
As a result of this relatively stiffer heart, we’re going to have regurgitant flow.
04:02
At some point, the valve will not close appropriately, and as we get regurgitant flow
into the atrium and then into the pulmonary circulation, we will have atrial fibrillation.
04:13
But, number one cause of atrial fibrillation is left atrial dilation. And as we increase
volume and pressure retrograde into the pulmonary circulation, now we’re going to have
pulmonary edema, congestive heart failure. So, long-term hypertensive changes in the
heart will lead to arrhythmias, pulmonary edema, diastolic dysfunction.